All the news Showing 10 of 52 articles from: Transmission and preventionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Universal hepatitis C screening in pregnancy improves case detection Keith Alcorn / 23 February 2022 Implementing universal testing for hepatitis C during pregnancy improved case detection 7.5-fold compared to the previous regime of risk-based screening, a research group from the University of Pittsburgh reported last week at the ... Australia on track to eliminate hepatitis C among gay and bisexual men before 2030 Krishen Samuel / 10 December 2021 Access to direct-acting antivirals to cure hepatitis C has slashed incidence rates for groups most affected in Australia. Among gay and bisexual men living with HIV, incidence fell by 78% ... New cases of hepatitis C have fallen among gay and bisexual men with HIV in France Keith Alcorn / 22 October 2021 The rate of new hepatitis C infections halved among gay and bisexual men with HIV in France between 2014 and 2017 following the introduction of direct-acting antivirals, a French cohort study has ... High prevalence of viral hepatitis among healthcare workers in Africa Keith Alcorn / 21 June 2021 Almost 7% of healthcare workers in Africa have hepatitis B and 5% have hepatitis C, according to a systematic review of published studies. Greater efforts to vaccinate against hepatitis B and improve ... What happens after curing hepatitis C? Avoiding, minimising or accepting the risks of re-infection Krishen Samuel / 14 June 2021 Swiss men living with HIV approach the risk of re-infection with hepatitis C after cure in different ways, based on recent qualitative research by Dr Patrizia Künzler-Heule and colleagues from the Universities of ... Hepatitis C declining among drug users in UK Keith Alcorn / 11 February 2021 The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ... Hepatitis C vaccine fails to prevent chronic infection Liz Highleyman / 10 October 2019 An experimental two-part vaccine was not able to prevent chronic hepatitis C virus (HCV) infection in a mid-stage study, according to a presentation at the recent IDWeek 2019 conference in Washington, DC. Prof. Andrea ... Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs Michael Carter / 26 November 2018 Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. ... Recent incarceration increases HIV and hepatitis C risk for people who inject drugs Michael Carter / 19 November 2018 People who inject drugs (PWID) recently released from prison or jail have a substantially increased risk of acquiring infection with HIV or hepatitis C virus (HCV), according to the results of a systematic ... People who inject drugs have a high hepatitis C cure rate despite imperfect adherence Liz Highleyman / 15 November 2018 Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ... ← First12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive